Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Creutzig

Showing results (11-20 of 158) with videos related to

Pageof 16
Sort By:
Haematology and Blood Transfusion|January 1, 1987
Effective remission induction in children with recurrent acute myeloid leukemia by mAMSA, Ara-C, and VP 16F Berthold, U Creutzig, F Lampert
Medical Oncology and Tumor Pharmacotherapy|January 1, 1985
Treatment of acute myelogenous leukemia in childrenG Schellong, U Creutzig, J Ritter
Klinische Padiatrie|April 29, 2005
Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blastsC Langebrake, U Creutzig, D Reinhardt
Haematology and Blood Transfusion|January 1, 1990
Improved treatment results in the myelocytic subtypes FAB M1-M4 but not in FAB M5 after intensification of induction therapy: results of the German childhood AML studies BFM-78 and BFM-83J Ritter, U Creutzig, G Schellong
Klinische Padiatrie|July 1, 1996
[Guidelines for diagnosis and therapy in in pediatric oncology and hematology]U Creutzig, K Winkler, G Henze
Leukemia|January 1, 1992
Treatment results of three consecutive German childhood AML trials: BFM-78, -83, and -87. AML-BFM-GroupJ Ritter, U Creutzig, G Schellong
Leukemia|November 24, 2005
Pediatric acute myeloid leukemia: international progress and future directionsG J L Kaspers, U Creutzig
Gematologiia I Transfuziologiia|January 1, 1991
[Intensification of chemotherapy of acute myeloid leukemia in children: report on the studies of the AML-BFM 78 and AML-BFM 83 protocols]U Creutzig, I Ritter, G Schellong
Klinische Padiatrie|November 9, 2010
[Results of the Competence Net Pediatric Oncology and Haematology--a view back]U Creutzig, R Herold, G Henze
Klinische Padiatrie|February 2, 2002
[Neuropsychological sequelae in children with AML treated with or without prophylactic CNS-irradiation]D Reinhardt, C Thiele, U Creutzig, et al.
Pageof 16

Showing results (11-20 of 158) with videos related to

Sort By:
Pageof 16
Haematology and Blood Transfusion|January 1, 1987
Effective remission induction in children with recurrent acute myeloid leukemia by mAMSA, Ara-C, and VP 16F Berthold, U Creutzig, F Lampert
Medical Oncology and Tumor Pharmacotherapy|January 1, 1985
Treatment of acute myelogenous leukemia in childrenG Schellong, U Creutzig, J Ritter
Klinische Padiatrie|April 29, 2005
Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blastsC Langebrake, U Creutzig, D Reinhardt
Haematology and Blood Transfusion|January 1, 1990
Improved treatment results in the myelocytic subtypes FAB M1-M4 but not in FAB M5 after intensification of induction therapy: results of the German childhood AML studies BFM-78 and BFM-83J Ritter, U Creutzig, G Schellong
Klinische Padiatrie|July 1, 1996
[Guidelines for diagnosis and therapy in in pediatric oncology and hematology]U Creutzig, K Winkler, G Henze
Leukemia|January 1, 1992
Treatment results of three consecutive German childhood AML trials: BFM-78, -83, and -87. AML-BFM-GroupJ Ritter, U Creutzig, G Schellong
Leukemia|November 24, 2005
Pediatric acute myeloid leukemia: international progress and future directionsG J L Kaspers, U Creutzig
Gematologiia I Transfuziologiia|January 1, 1991
[Intensification of chemotherapy of acute myeloid leukemia in children: report on the studies of the AML-BFM 78 and AML-BFM 83 protocols]U Creutzig, I Ritter, G Schellong
Klinische Padiatrie|November 9, 2010
[Results of the Competence Net Pediatric Oncology and Haematology--a view back]U Creutzig, R Herold, G Henze
Klinische Padiatrie|February 2, 2002
[Neuropsychological sequelae in children with AML treated with or without prophylactic CNS-irradiation]D Reinhardt, C Thiele, U Creutzig, et al.
Pageof 16